Conakry

Resilience System


You are here

Senegal

WHO Urges Stronger Regulations on Vaccines in China

WHO Urges Stronger Regulations on Vaccines in China

 

 
 
 
BEIJING—

China needs to more closely regulate the market for private vaccines within its borders, the World Health Organization said Tuesday after authorities broke up a massive illegal drug ring earlier this month.

Police in China arrested more than 130 people allegedly involved in the illegal drug trade after the group dumped around $48 million worth of illegal vaccines onto the private Chinese drug market. Much of the medicine had expired before it was sold.

“This incident has highlighted the need for more, stricter enforcement of vaccine management regulations across the board,” WHO China representative Bernhard Schwartlander said in an email.

According to Chinese police, a woman and her daughter, who have since been arrested, led the drug ring and sold more than $100 million worth of illegal vaccines across the country since 2001.

Private sellers

All told, 29 pharmaceutical companies are believed to have sold the illegitimate drugs to 16 institutions.

Meeting / Event Tags: 
General Topic Tags: 
Problem, Solution, SitRep, or ?: 

With Many Ebola Survivors Ailing, Doctors Evaluate Situation

ASSOCIATED PRESS  by Carley Petesch              Aug. 23, 2015

DAKAR, Senegal --Lingering health problems afflicting many of the roughly 13,000 Ebola survivors have galvanized global and local health officials to find out how widespread the ailments are, and how to remedy them.

The World Health Organization calls it an emergency within an emergency. Many of the survivors have vision and hearing issues. Some others experience physical and emotional pains, fatigue and other problems. The medical community is negotiating uncharted waters as it tries to measure the scale of this problem that comes on the tail end of the biggest Ebola outbreak in history.

"If we can find out this kind of information, hopefully we can help other Ebola survivors in the future," Dr. Zan Yeong, an eye specialist involved in a study of health problems in survivors in Liberia, told The Associated Press.

About 7,500 people will enroll — 1,500 Ebola survivors and 6,000 of their close contacts — and will be monitored over a five-year period in the study launched by Partnership for Research on Ebola Vaccines in Liberia, or PREVAIL.

Read complete story.

General Topic Tags: 
Problem, Solution, SitRep, or ?: 

WHITE HOUSE FACT SHEET: The Global Health Security Agenda

The U.S. Government announces it intends to invest more than $1 billion in resources to expand the Global Health Security Agenda to prevent, detect, and respond to future infectious disease outbreaks overseas.

THE WHITE HOUSE PRESS OFFICE                       July 28, 2015

The Ebola epidemic in West Africa continues to galvanize global attention and resources as the international community strives to eliminate active cases and help the affected countries recover.  African leaders and African Union officials have shown extraordinary leadership in addressing the outbreak. The epidemic highlighted the urgent need to establish global capacity to prevent, detect, and respond to biological threats – to prevent future outbreaks from becoming epidemics. 

Beginning with the release of the National Strategy for Countering Biological Threats in 2009, and outlined in his 2011 speech at the United Nations General Assembly, President Obama has called upon all countries to come together to prevent, detect, and respond to infectious disease threats, whether naturally occurring, accidental or deliberately spread.  Today, the President underscored the unwavering U.S. commitment to partnering with Africans, their governments, and all who will join the effort to improve health security across the continent and for all people.

Problem, Solution, SitRep, or ?: 

Tourists abandon Ghana despite its successes against Ebola

HUMANOSPHERE  by Tom Murphy                                                                          May 1, 2015

ELMINA, Ghana – Each evening the fishermen set out in their hand-carved wooden boats. By nightfall, the horizon is dotted by a long row of small lights, their own constellation. Fish are caught, the haul is sold in markets and life continues. But one group is noticeably absent from Elmina and other towns along Ghana’s coast – tourists.

The near-empty Elmina Bay Resort. (Credit: Tom Murphy)

Thousands of college students embark on a trip to see the world and do a bit of learning through the Semester at Sea program. The West African countries of Senegal and Ghana are usually on the itinerary, bringing a steady flow of tourism to the two countries. But the countries are not destinations for three consecutive semesters due to concerns about Ebola.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Africa tourism acts to shake off Ebola stigma

AFP  by Marie Julie                                                                                                        March 7, 2015
Berlin - - The impact of the deadly Ebola virus fell mainly on three African countries but tourism has taken a hit across the continent of more than 50 nations as fear has kept many visitors away, tourism chiefs say.

Visitors pass by a poster of flight route information at the 49th International Tourism Fair (ITB Berlin 2015) in Berlin on March 4, 2015 (AFP Photo/Tobias Schwarz)

Some 56 million tourists visited Africa in 2014, a two-percent rise from the previous year, according to UNWTO figures, but growth in Africa lagged behind that in Europe, Asia or the Americas.

Africa had seen a robust 4.8-percent increase in tourists a year earlier.

"Africa... did well (last year) in spite of suffering from the Ebola symptoms which were associated unfairly" with Africa as a whole, Taleb Rifai, head of the UN World Tourism Organization (UNWTO), said at the Berlin tourism fair (ITB).

He said Africa needed support, especially after the Ebola crisis, adding: "It was very unfair the generalisation that happened."

Problem, Solution, SitRep, or ?: 

Botswana Doctor Is Named to Lead W.H.O. in Africa

NEW YORK TIMES  by Donald G. McNeil, Jr.                                                               Jan. 27, 2015

A defining moment in the life of Dr. Matshidiso Moeti, the World Health Organization’s new regional director for Africa, came when she was 9 and her father realized that her little sister’s mathematics textbook was below even the level he had studied as a poor child on a South African farm.

General Topic Tags: 
Problem, Solution, SitRep, or ?: 

Senegal reopens land border with Ebola-hit Guinea

REUTERS                                                                                                        Jan. 26, 2015

DAKAR --Senegal reopened on Monday its land border with Guinea, the Interior Ministry said, five months after closing transport links in August to prevent the spread of the worst outbreak on record of the deadly Ebola virus.

A billboard with a message about Ebola is seen on a street in Conakry, Guinea October 26, 2014.Credit: Reuters/Michelle Nichols

Senegal had already lifted in November a ban on air and maritime traffic with Guinea, Liberia and Sierra Leone - the three countries worst-affected by the epidemic of the deadly hemorrhagic fever....

"The decision to open the border follows meetings between Senegalese and Guinean authorities, in the course of which the important efforts made by the sister republic of Guinea to fight the Ebola virus were noted," said a ministry statement.

Read complete story.

http://www.reuters.com/article/2015/01/26/us-health-ebola-senegal-idUSKBN0KZ1GW20150126

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Ebola in Graphs: The toll


THE ECONOMIST                                                                                                    Jan. 1, 2015
THE first reported case in the Ebola outbreak ravaging west Africa dates back to December 2013, in Guéckédou, a forested area of Guinea near the border with Liberia and Sierra Leone. Travellers took it across the border: by late March, Liberia had reported eight suspected cases and Sierra Leone six. By the end of June 759 people had been infected and 467 people had died from the disease, making this the worst ever Ebola outbreak. The numbers keep climbing. As of December 28th, 20,206 cases and 7,905 deaths had been reported worldwide, the vast majority of them in these same three countries. Many suspect these estimates are badly undercooked.
See complete set of graphs.
http://www.economist.com/blogs/graphicdetail/2015/01/ebola-graphics

Problem, Solution, SitRep, or ?: 

Ebola’s lessons, painfully learned at great cost in dollars and human lives

In-Depth report on lessons to be learned from the Ebola crisis

THE WASHINGTON POST by By Lena H. Sun, Brady Dennis and Joel Achenbach                            Dec. 29, 2014

A year after it began, the Ebola epidemic in West Africa continues to be unpredictable, forcing governments and aid groups to improvise strategies as they chase a virus that is unencumbered by borders or bureaucracy.

The people fighting Ebola are coming up with lists of lessons learned — not only for the current battle, which has killed more than 7,500 people and is far from over, but also for future outbreaks of deadly contagions.

Alice Jallabah, head of a bushmeat seller group, holds dried bushmeat in Monrovia. (Zoom Dosso/AFP/Getty Images)

Problem, Solution, SitRep, or ?: 

GSK Ebola vaccine trial seen moving to wider phase in February

REUTERS                                                                                              Dec. 19, 2014

Trials of GlaxoSmithKline's experimental Ebola vaccine are likely to move to a second phase in February, later than previously suggested, after a meeting of national regulators said they needed more information.

The World Health Organization, which hosted a meeting of national regulatory authorities and ethics committees earlier this week, said they had thoroughly discussed all aspects of the proposed trials at the two-day meeting.

"Reviewing countries requested additional documentation from the manufacturer of the vaccine, GlaxoSmithKline, before authorization of the trials," the WHO said in a statement.

Countries where the trials are planned -- Cameroon, Ghana, Mali, Nigeria and Senegal -- should receive and review the additional information by the end of January.

"If these steps are completed to the satisfaction of the national authorities, Phase II trials are likely to begin in February," the statement said.

The GSK vaccine is already undergoing Phase I trials, to check its safety in humans, in Switzerland, Britain, Mali and the United States, and is one of the two leading candidate vaccines for Ebola already undergoing tests.

General Topic Tags: 
Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Senegal
howdy folks